Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Immunofluorescence double labeling method based on same species source first antibody

An immunofluorescence and double labeling technology, applied in the fields of biomedicine and biotechnology, to avoid cross-reaction, avoid immune cross-reaction, and solve the limited source of antibody species

Inactive Publication Date: 2014-08-20
FOURTH MILITARY MEDICAL UNIVERSITY
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] In order to solve the problem that the existing immunofluorescence double labeling technology must use two different kinds of primary antibodies, the present invention provides a new immunofluorescence chemical staining technology, which uses limited antibody species sources and ordinary fluorescent microscopes to realize the same species Double labeling with primary antibodies of genus origin in the same specimen

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Immunofluorescence double labeling method based on same species source first antibody
  • Immunofluorescence double labeling method based on same species source first antibody

Examples

Experimental program
Comparison scheme
Effect test

Embodiment l

[0034] Embodiment 1: The co-expression of TH (A protein) and P75 (B protein) was detected by the immunofluorescence double-labeling technique described in the present invention, and the primary antibodies used were all rabbit-derived , including the following steps:

[0035] (1) Determine the minimum working concentration of rabbit anti-TH antibody:

[0036] (a) Flat-frozen tissue sections of the coeruleus coeruleus in the midbrain of neonatal mice were washed in 0.01 mol / L PBS three times for 5 minutes each time;

[0037] (b) Add normal goat serum blocking solution and incubate in a humid box at 37°C for 60 minutes. Pay attention to keep the sample moist, and be sure to avoid drying the tissue slices, otherwise a high background will be produced;

[0038] (c) According to the concentration recommended in the instruction manual of rabbit anti-TH antibody (Sigma, Cat. No. T-8700), dilute the antibody in a two-fold gradient with antibody diluent (containing 1% BSA and 0.3% T...

Embodiment 2

[0055] Example 2: The cultured neural stem cell slides were detected by the immunofluorescence double labeling technique of the present invention to detect the co-expression of Ki67 (A protein) and BrdU (B antigen). The primary antibodies used were all mouse-derived, including the following steps:

[0056] (1) Determine the minimum working concentration of mouse anti-Ki67 antibody:

[0057] (a) The slides of cultured neural stem cells were fixed in 4% paraformaldehyde for 20 minutes, and washed three times with 0.01 mol / L PBS for 5 minutes each time;

[0058] (b) Add normal goat serum blocking solution and incubate in a humid box at 37°C for 30 minutes;

[0059] (c) According to the recommended concentration of the mouse anti-Ki67 antibody (Abcam, Cat. No. ab6526), ​​use the antibody diluent to dilute the antibody in a two-fold gradient. The specific dilution ratios are 1:200, 1:400, 1:800, 1:1500, 1:3000, add to the cell slides to be tested, and incubate at 4°C for 24 hour...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an immunofluorescence double labeling method based on the same species source first antibody. The method comprises the steps of: (1) conducting gradient dilution of anti A antibody, and determining anti A protein antibody and measuring the minimum working concentration of the A protein to be detected by using an indirect immunofluorescence staining method; (2) developing the A protein by using the concentration and an SABC method (using luorescein to label streptavidin); (3) applying anti B protein antibody, and developing the B protein by an indirect immunofluorescence staining method; and (4) conducting microscopic examination by a fluorescence microscope, taking photos, overlaying the microscopic examination photos of the A protein and B protein to be detected, and analyzing the expression of the two proteins. The method is simple and easy for operation, realizes high research requirements with low experiment cost, and provides a wide range of applications for the chemical study of clinical immunofluorescence tissue.

Description

technical field [0001] The invention belongs to the application fields of biomedicine and biotechnology, and specifically relates to a method for immunofluorescent double labeling by using two primary antibodies from the same species. Background technique [0002] In biological and medical research, immunofluorescent chemical staining is one of the most commonly used technical means. Its principle is to use the principle of specific binding of antigen and antibody, combine with fluorescein labeled on the antibody, and irradiate the fluorescein with excited light. And it emits bright fluorescence (yellow-green or orange-red) so that the localization, qualitative and quantitative information of tissue, intracellular polypeptide or protein antigen can be visualized under a fluorescent microscope. [0003] During the research process, it is often necessary to detect two antigens / proteins (such as protein A and protein B) simultaneously in the same cell or tissue sample to clarif...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N1/30
Inventor 史明杜芳
Owner FOURTH MILITARY MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products